Volume 12 (2026) | undefined

All Journals All Articles | Search Log In

About
Publish with us
Articles
Special Topics
Volumes
Features

+ Subscribe

Home

Articles Special Topics Volumes Webinars Videos

Please enter the verification code in the image

Please enter the verification code in the image

Add Your E-Mail Address To Receive Forthcoming Issues Of This Journal:

Email:

Home

Articles Special Topics Volumes Webinars Interviews

Home Volumes

Volume

Table of Contents (60 articles)

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

Man Kit Christopher Chu, ... Man Tong

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Ningrui Su, ... Da Zhou

Rewiring the tumor microenvironment in hepatocellular carcinoma: mechanism-driven integration of immunotherapy and locoregional strategies

Meng Li, ... Jiachang Chi

Jiachang Chi

Exploring the molecular pathology and tumor microenvironment in gastric cancer liver metastasis

Jialu Zhuang, ... Hongping Xia

Hongping Xia

Molecular characteristics of fatty acid metabolic reprogramming in hepatocellular carcinoma and their implications for immunotherapy

Diyu Chen, ... Zheng Tang

Converse therapeutic hierarchy in hepatocellular carcinoma

Francesco Tovoli

Francesco Tovoli

, ...

Application of ex vivo liver perfusion in hepatoma research

Ben Brown, ... John Isherwood

The evolving role of contrast-enhanced ultrasound in hepatocellular carcinoma: from diagnosis to therapeutic monitoring

Ludovico Abenavoli, ... Domenico Laganà

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

Zhao Ruan, ... Xuedan Sun

The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients

Ilaria Govoni, ...

Reconstructing strategies for precision diagnosis and treatment of liver cancer based on multi-modal data

Run-Ze Miao, ... Xin-Rong Yang

Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma

Argyro Voumvouraki, ... Elias Kouroumalis

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Youzhi Lin, ... Xiaoli Liao

Xiaoli Liao

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma

Chunyi Zhu, ... Tao Peng

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Weili Jia, ... Rong Liu

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Chalv Fu, ... Chuanzhou Li

Chuanzhou Li

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Tingjiang He, ... Qianwei Zhao

Qianwei Zhao

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Luca Risi, ... Luca Viganò

Luca Viganò

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Lu Han, ... Fei Song

Fei Song

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Bailey Hall, ... Jon Davidson

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Yang Wang

Yang Wang

, ... Xin-Rong Yang

Incretin-based therapies: a new era in metabolic liver disease management

Sakktivel Elangovan

Sakktivel Elangovan

, ... George Boon-Bee Goh

An activated CD8⁺ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Zong Wu, ... Yongfa Zhang

Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

Qichao Fan, ... Jiaofeng Huang

Targeting gut microbiota to overcome immunotherapy resistance in hepatocellular carcinoma: from mechanisms to clinical practice

Jie Wang, ... Runqiu Jiang

Regional dietary patterns and risk of primary liver cancer in Anhui, China: a population-based case-control study

Yu Chang

Yu Chang

, ... Wanshui Yang

A systematic review of comparative economic analyses of systemic therapies for hepatocellular carcinoma

Paolo De Simone

Paolo De Simone

, ... Fabio Vistoli

A review on decellularization scaffolding for liver regeneration in transplantation

Yichen Liu, ... Kai-Wen Huang

Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies

Taishun Mao, ... Limin Xia

Limin Xia

Gut microbiota as predictors of immunotherapy response in hepatocellular carcinoma

Shufen Xia, ... Shixian Hu

Shixian Hu

Global burden of liver cancer mortality due to alcohol use from 1990 to 2021 and predictions to 2050

Jingyue Tan, ... Yuan Wang

Multidisciplinary management of HCC

Alessandro Vitale

Precision medicine in metabolic dysfunction-associated steatotic liver disease: genetics, epigenetics, and emerging therapies

Eunho Choi, ...

From algorithm to dialogue: interpreting the 2026 BCLC-CUSE strategy for HCC care

Ralf Weiskirchen

Ralf Weiskirchen

, ... Amedeo Lonardo

Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives

Giacinta Ciancimino, ... Salvatore Petta

Synergistic era: practice and reflection on TACE combined with systemic therapy in hepatocellular carcinoma

Chenghui Li, ... Guangyu Zhu

Malnutrition in MASLD-related hepatocellular carcinoma: assessment limitations, multidimensional mechanisms, and microbiome-based interventions

Baizhen Huang, ... Yutong Sui

When a hazard ratio is not enough: non-proportional hazards are reshaping the interpretation of phase III trials in hepatocellular carcinoma

Erica Villa

Erica Villa

Rewiring neurotrophic signaling to escape targeted therapy in hepatocellular carcinoma

Daolin Tang

Daolin Tang

, ... Rui Kang

From platforms to pathways: imaging innovation, quantitative biomarkers, and clinical translation in hepatocellular carcinoma

Yuqi Huang, ... Jing Cai

Clinical applications and advances in noninvasive prognostic assessment of metabolic dysfunction-associated steatotic liver disease

Xin-Long He, ... Jian-Gao Fan

Pseudocirrhosis: pathophysiology, clinical mimics, and its role in hepatocellular carcinoma diagnosis and management

Paolo Gallo

Paolo Gallo

, ... Antonio Picardi

Fibroblast growth factor 21 in metabolic dysfunction-associated steatotic liver disease and beyond: from bench to bedside

Hak-Keith Leung, ... Wah-Kheong Chan

Relationship between transarterial chemoembolization treatment frequency and prognosis in hepatocellular carcinoma patients

Yu-Yan Ma, ... Hai-Dong Zhu

Evolving epidemiology and antimicrobial resistance in cirrhosis: time for a region-specific approach

Aikaterini Gkoufa, ... Evangelos Cholongitas

Pharmacological chemoprevention of hepatocellular carcinoma: hype, hope, or reality?

Ralf Weiskirchen

Ralf Weiskirchen

, ... Amedeo Lonardo

Amedeo Lonardo

Beyond scarcity: rethinking transplant candidacy in the era of pig-to-human liver xenotransplantation

Alessandro Vitale

Alessandro Vitale

, ... Umberto Cillo

Umberto Cillo

From gut-liver axis hijacking to intratumoral microbiota establishment: mechanisms and therapeutic opportunities in hepatocellular carcinoma

Silei Xu, ... Weikang Chen

Advancing immunotherapy and tumor microenvironment research in hepatocellular carcinoma

Lianxin Liu

Semaglutide and resmetirom for MASH: the AASLD Practice Guidance tells us when, not which

Jakob Weglage, ... Frank Tacke

Is the second recurrence peak in HBV-related HCC fading in the antiviral era?

Kuo Chao Yew

Kuo Chao Yew

, ... Joseph J.Y. Sung

Joseph J.Y. Sung

Metabolic memory and immune evasion in MASLD-HCC progression

Qinghao Song, ... Yutong Sui

An immunocompetent model of hepacivirus-associated liver fibrosis and hepatocellular carcinoma

Takahiro Ochiya

Combining locoregional and systemic therapies in liver cancer: from strategy to survival

Bin-Yan Zhong

Is nicotinamide adenine dinucleotide the Achilles’ heel of chronic interleukin-6 signaling in cholangiocarcinoma?

Magdalena Hahn

Magdalena Hahn

, ... Mathias Heikenwälder

Mathias Heikenwälder

Chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: converging pathobiology, hepatocarcinogenesis, and clinical implications in the post-SVR era

Mohamed El-Kassas

Mohamed El-Kassas

, ... Abdel-Naser Elzouki

The gut microbiome and the pathogenesis of trans-arterial chemoembolization-associated liver injury

Jared Engelman, ... Stephen M. Riordan

Gut microbiota in hepatocellular carcinoma: pathogenic mechanisms and clinical translation

Kehan Zhang, ... Lina Wang

Green tea consumption and hepatocellular carcinoma: a meta-analysis lacking evidence for a protective effect

Siting Ling, ... Guangwen Cao

Future perspective of GLP-1 receptor agonists across the spectrum of steatotic liver disease

Kamela Gjini, ... Angelo Armandi

Actions for 0 selected articles

Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

[email protected]

Navigation

Follow Us

LinkedIn
Twitter
Academia
Google Scholar

Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

[email protected]

Contact Us

Language Editing

Layout & Production

Graphical Abstract

Conference Organizer

Strategic Collaborator

Follow OAE

© 2016-2026 OAE Publishing Inc., except certain content provided by third parties

Privacy Cookies Terms of Service